Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The programme is designed to offer an overview of recent research activities in this area and review the current status and future prospect of CDK4-6 inhibitors in HR-positive/HER2-negative early breast cancer.
The programme is designed to offer an overview of research activities in this area and review the current status and future prospect of testing and targeting various tumours with RET alterations.
The programme is designed to offer an overview of research activities in this area and review the current status and future prospects of CDK4-6 inhibitors in breast cancer.
This Webinar series has been organised with the aim to share the ESMO adapted recommendations for cancer patient management during the COVID-19 pandemic.
The programme is designed to offer an overview of research in this area and review the current status and future prospects of immunotherapy in HNSCC.
The programme is designed to offer an overview of research in this area and review the current status and future prospects of immunotherapy in breast cancer.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
